Givaudan SA Stock (CH0010645932): Consensus Hold Rating from Seven Brokerages

Givaudan SA (CH0010645932) has received a consensus 'Hold' rating from seven brokerages, including two sells, three holds, and two buys. The stock opened at $71.82 on OTCMKTS:GVDNY on April 25, 2026, below its 200-day moving average of $78.57.

Givaudan SA shares have received a consensus recommendation of "Hold" from seven ratings firms covering the company, according to data as of April 25, 2026. The breakdown includes two sell ratings, three hold ratings, and two buy ratings. This mixed sentiment reflects recent analyst actions, including a buy reiteration from Deutsche Bank and downgrades to hold from Barclays and Berenberg, alongside a sell cut from Goldman Sachs.

The stock opened at $71.82 on the OTCMKTS:GVDNY on April 25, 2026, below its 200-day moving average of $78.57. Recent stock performance shows Givaudan within a 52-week range of $65.97 to $103.39.

As of: May 05, 2026

By the AD HOC NEWS Editorial Team – Equity Coverage.

At a Glance

• Name: Givaudan
• ISIN: CH0010645932
• Sector/Industry: Materials/Chemicals - Specialty
• Headquarters/Country: Vernier, Switzerland
• Primary Exchange: SIX Swiss Exchange (GIVN.SW), OTC (GVDNY)
• Trading Currency: CHF (primary), USD (OTC) with FX risk

How Givaudan Makes Money: The Core Business Model

Givaudan operates as a global leader in flavors and fragrances. The company develops, manufactures, and sells taste and wellbeing solutions as well as perfumes for consumer products. Revenue derives primarily from sales to major food, beverage, consumer goods, and fragrance companies worldwide.

The business model centers on research and development investment to create proprietary flavor and fragrance compounds. These are sold under long-term supply agreements to multinational clients in the food, beverage, personal care, and household products sectors.

Givaudan maintains production facilities across multiple continents to serve regional markets efficiently. The company focuses on innovation in natural ingredients and sustainable sourcing to meet regulatory and consumer trends.

Givaudan's Key Revenue and Product Drivers

Taste & Wellbeing solutions represent a core revenue driver, encompassing flavors for food and beverages. Fragrance division contributes through perfumes for fine fragrances, personal care, and home care products. The company serves leading global brands in these categories.

Geographic revenue distribution includes significant exposure to Europe, North America, and Asia-Pacific. Growth stems from acquisitions expanding product portfolios and market reach in emerging regions.

Recent developments highlight ongoing investment in sustainable ingredients and digital tools for product development. These initiatives support client demands for clean-label and eco-friendly formulations.

Industry Trends and Competitive Landscape

The flavors and fragrances industry faces trends toward natural, organic ingredients and reduced synthetic additives. Regulatory pressures in the EU and US drive reformulation efforts across the sector.

Competitors include International Flavors & Fragrances (IFF), Symrise AG, and Firmenich (now part of DSM-Firmenich). These peers operate similar global models focused on R&D-intensive product innovation.

Market consolidation through mergers and acquisitions remains active, as companies seek scale in R&D and supply chain capabilities. Demand growth persists in health-oriented food and premium personal care segments.

Why Givaudan Matters to US Investors

Givaudan trades on US OTC markets as GVDNY, providing US investors access without direct SIX Swiss Exchange exposure. The OTC listing enables trading in USD, though with inherent FX risk versus the primary CHF denomination.

US market relevance includes exposure through North American revenue streams and major consumer goods clients based in the United States. SEC filings are not required as a foreign private issuer, but OTC transparency supports investor access.

The company's global footprint includes significant US operations, aligning with investor interest in multinational specialty chemicals with defensive characteristics.

Which Investor Profile Fits Givaudan – and Which Does Not?

Investors focused on stable, innovation-driven sectors like consumer staples may find alignment with Givaudan's business model. The company's emphasis on R&D and long-term client relationships suits those seeking exposure to non-cyclical growth.

Profiles prioritizing high dividend yields or rapid tech sector expansion may seek alternatives. Givaudan's profile centers on steady compounding through margin expansion and market share gains in niche segments.

Long-term holders interested in ESG trends benefit from the company's sustainability initiatives in natural ingredients and supply chain practices.

What Analysts Are Saying About Givaudan Stock

Seven brokerages maintain coverage, resulting in the consensus Hold rating as of April 25, 2026. Recent actions include Deutsche Bank reiterating Buy alongside downgrades from Barclays and Berenberg to Hold, and Goldman Sachs adjusting to Sell.

This distribution reflects balanced views on valuation amid industry headwinds and growth opportunities in premium segments.

Risks and Open Questions for Givaudan

Raw material cost volatility poses ongoing challenges, particularly for natural ingredients subject to commodity price swings. Regulatory changes in food safety and chemical usage across regions add compliance burdens.

Intense competition from integrated peers pressures margins in key segments. Currency fluctuations impact reported results given multinational operations.

Supply chain disruptions from geopolitical events or climate factors remain a concern for global sourcing networks.

Conclusion

The consensus Hold rating from seven brokerages underscores mixed analyst views on Givaudan SA as of April 25, 2026. Recent adjustments including downgrades from Barclays, Berenberg, and Goldman Sachs balance against Deutsche Bank's Buy reiteration. US investors access the stock via OTCMKTS:GVDNY at an opening of $71.82 on April 25, 2026, within a 52-week range of $65.97 to $103.39. The company's position in flavors and fragrances continues to draw attention amid industry trends toward sustainability and premium products.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.